WuXi ATU and GeneMedicine Sign Development and Manufacturing Agreement for Oncolytic Virus Products

By In The News
November 29, 2019 in The Headlines

Recommended Posts

In The News

Posted November 29, 2019

- Share

Posted November 29, 2019

SHANGHAI and SEOUL, South Korea, Nov. 28, 2019 /PRNewswire/ -- WuXi ATU Co., Ltd., (WuXi ATU) - a subsidiary of WuXi AppTec, and GeneMedicine - a South Korea-based gene therapy biotechnology company, have formed a strategic partnership for the development and manufacturing of oncolytic...

View the full article

Link to comment

Share on other sites

Archived

This topic is now archived and is closed to further replies.

Go to topic listing

Most Contributions
1. In The News
  221738
2. Jaydee
  17628
3. deicer
  13178
4. Kip Powick
  12287
5. dagger
  9605
Tell a friend
Love The Airline Website? Tell a friend!
- Email
- Share
Forum Statistics
- Total Topics
  
  272.1k
- Total Posts
  
  564k

Sign In

WuXi ATU and GeneMedicine Sign Development and Manufacturing Agreement for Oncolytic Virus Products

Recommended Posts

In The News

Link to comment

Share on other sites

Archived

Most Contributions

Tell a friend

Forum Statistics

Browse

Activity

Support